![Frederick M. Miesowicz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frederick M. Miesowicz
Keine laufenden Positionen mehr
Profil
Dr. Frederick M.
Miesowicz is Chief Operating Officer & VP-Manufacturing at Argos Therapeutics, Inc.
Dr. Miesowicz was previously employed as Vice President-US Operations by Gamida Cell Ltd., Senior Vice President & General Manager by Hybridon Specialty Products, Vice President & General Manager by Cellcor, Inc., a Principal by Terumo Medical Corp., and Vice President by Dupont de Nemours.
He received his undergraduate degree from Siena College and a doctorate degree from Harvard University.
Ehemalige bekannte Positionen von Frederick M. Miesowicz
Unternehmen | Position | Ende |
---|---|---|
ARGOS THERAPEUTICS, INC. | Geschäftsführer | 22.04.2016 |
GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Hybridon Specialty Products | Corporate Officer/Principal | 01.01.2000 |
Cellcor, Inc.
![]() Cellcor, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Cellcor, Inc. is a company that specializes in the development of cellular therapies. The company is based in Newton, MA. Cellcor was acquired by Jazz Pharmaceuticals (EUSA Pharma USA), Inc., part of Jazz Pharmaceuticals Plc from May 09, 2008 on October 23, 1995 for $20 million. | Corporate Officer/Principal | 01.01.1998 |
DuPont de Nemours (Luxembourg) SARL
![]() DuPont de Nemours (Luxembourg) SARL Chemicals: SpecialtyProcess Industries DuPont de Nemours (Luxembourg) SARL manufactures synthetic resins, synthetic rubbers and industrial chemicals. It offers services to markets, such as agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation, and apparel. The company was founded in 1962 and is headquartered in Luxembourg. | Corporate Officer/Principal | - |
Ausbildung von Frederick M. Miesowicz
Harvard University | Doctorate Degree |
Siena College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GAMIDA CELL LTD. | Health Technology |
Private Unternehmen | 5 |
---|---|
Argos Therapeutics, Inc.
![]() Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Hybridon Specialty Products | |
Cellcor, Inc.
![]() Cellcor, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Cellcor, Inc. is a company that specializes in the development of cellular therapies. The company is based in Newton, MA. Cellcor was acquired by Jazz Pharmaceuticals (EUSA Pharma USA), Inc., part of Jazz Pharmaceuticals Plc from May 09, 2008 on October 23, 1995 for $20 million. | Commercial Services |
Terumo Medical Corp.
![]() Terumo Medical Corp. Medical SpecialtiesHealth Technology Terumo Medical Corp. manufactures and distributes medical products. It offers products through three business divisions: Terumo Interventional Systems, Terumo Medical Products, and Terumo Transfusion Products. The company was founded in 1972 and is based in Somerset, NJ. | Health Technology |
DuPont de Nemours (Luxembourg) SARL
![]() DuPont de Nemours (Luxembourg) SARL Chemicals: SpecialtyProcess Industries DuPont de Nemours (Luxembourg) SARL manufactures synthetic resins, synthetic rubbers and industrial chemicals. It offers services to markets, such as agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation, and apparel. The company was founded in 1962 and is headquartered in Luxembourg. | Process Industries |